Evidence map›Paper›PMID 28270399›Full record

ArticleBMJ case reports2017

Tuberculous periprosthetic infection precipitated by infliximab therapy.

Rajesh Malhotra, Deepak Gautam, Naman Wahal

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Management ofOpen forum infectious diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rajesh MalhotraDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Deepak GautamDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Naman WahalDepartment of Orthopaedics, All India Institute of Medical Sciences, New Delhi, Delhi, India.
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological therapy with TNF-α inhibitors have been increasingly used in the treatment of inflammatory arthritis. Systemic tuberculosis infections are often known to occur following treatment with these biological agents. However, no case of periprosthetic tuberculous infection of the hip following this therapy has been reported. We report a case of a 45-year-old man who developed periprosthetic tuberculous infection soon after infliximab injection. We also discuss the need of pretreatment awareness, high index of suspicion, early diagnosis and management of such case.

Indexed as

Antirheumatic AgentsArthroplasty, Replacement, HipHip ProsthesisHumansImmunosuppressive AgentsInfliximabMaleMiddle AgedPostoperative ComplicationsProsthesis-Related InfectionsTomography, X-Ray ComputedTuberculosis, OsteoarticularAntirheumatic AgentsImmunosuppressive AgentsInfliximab

Identifiers

PMID28270399
PMCPMC5353387
OpenAlexW2594231593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.